• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconOzempic

Ozempic

Page 6 of 9
A photo of the packet for anti-obesity drug Wegovy.
Tech
India’s gray market is selling Wegovy at less than 10% of U.S. prices—even though weight-loss drugs aren’t officially available in the country
By Satviki Sanjay and BloombergJune 19, 2024
Baggy pants are out and smaller sizes are flying off the shelves as Wegovy changes how Americans buy clothes
Retail
Baggy pants are out and smaller sizes are flying off the shelves as Wegovy changes how Americans buy clothes
By Marco Quiroz-GutierrezJune 17, 2024
Lars Fruergaard Jorgensen, chief executive officer of Novo Nordisk A/S, gestures while speaking during a Bloomberg Television interview in London, U.K.
Retail
Ozempic is 1,300% more expensive in the U.S. vs the U.K.—so the boss of Novo Nordisk is being hauled in front of Bernie Sanders to explain why
By Ryan HoggJune 17, 2024
CEO Sima Sistani didn’t think running WeightWatchers would be this hard
Newsletters
CEO Sima Sistani didn’t think running WeightWatchers would be this hard
By Emma Hinchliffe and Joey AbramsJune 11, 2024
Ozempic and Wegovy are so hard to find that a startup invented a free tool for tracking whether the viral drugs are in stock
Health
Ozempic and Wegovy are so hard to find that a startup invented a free tool for tracking whether the viral drugs are in stock
By Marco Quiroz-GutierrezMay 29, 2024
Semaglutide pen being injected into a person's thigh
Health
Could drugs like Ozempic and Wegovy help people live longer? Some experts see them as potential longevity pills
By Jessica FirgerMay 25, 2024
Dr. Razia Hashmi, vice president of clinical affairs, Blue Cross Blue Shield Association, speaks during Fortune’s Brainstorm Health conference in Dana Point, Calif., on Tuesday, May 21, 2024.
Health
GLP-1 drugs like Wegovy are all the rage—but people are quitting them too fast to achieve meaningful weight loss, finds 170,000-patient study
By Lindsey LeakeMay 22, 2024
Nestle CEO Mark Schneider
Retail
Nestlé’s new foods are getting Ozempified, with slashed portions priced specifically for those on weight-loss drugs
By Sasha RogelbergMay 21, 2024
Dr. Patrick Carroll (right), Hims & Hers chief medical officer, speaks during Fortune’s Brainstorm Health conference in Dana Point, Calif., Monday, May 20, 2024.
Conferences
Hims & Hers’ surprise 85% Wegovy discount is latest step on a journey to make medicine less ‘paternalistic,’ exec says
By Marco Quiroz-GutierrezMay 20, 2024
Senate Health, Education, Labor and Pensions Committee Chairman Bernie Sanders
Retail
Bernie Sanders urges Danish pharma giant Novo Nordisk to lower its drug prices: ‘Help the American people’
By Christian Wienberg and BloombergMay 13, 2024
woman measures her waist
Health
Weaning off Ozempic slowly instead of quitting abruptly can help prevent patients from regaining weight, study says
By Ashleigh Furlong and BloombergMay 11, 2024
Dirk Van De Put, chairman and chief executive officer of Mondelez International.
Retail
People will keep eating Oreos despite Ozempic surge, according to CEO of maker, Mondelez
By Deena Shanker and BloombergMay 3, 2024
Lars Fruergaard Jorgensen, chief executive officer Novo Nordisk
Retail
Denmark’s Novo Nordisk forecasts 27% sales surge but faces price pressure amid Eli Lilly competition
By Naomi Kresge and BloombergMay 2, 2024
Lars Fruergaard Jorgensen
Health
No evidence Ozempic and Wegovy raise risk of self harm, EU regulators said
By Jonel Aleccia and The Associated PressApril 12, 2024
Pascal Soriot, chief executive officer of Astrazeneca Plc, arrives at the CEO council at the Great Hall of the People in Beijing, Chin
Success
Major investors say AstraZeneca boss is ‘massively underpaid’ on $21.5 million salary, despite earning more than double Novo Nordisk’s CEO
By Ryan HoggApril 10, 2024
1...
  • 4
  • 5
  • 6
  • 7
  • 8
9
Most Popular
Economy
The stock market may be doing so well that it's causing more baby boomers and Gen Xers to drop out of the labor forceplaceholder alt text
By Jason MaAugust 10, 2026
AI
How stalled models, missed deadlines, and staff burnout led to the unraveling of Google's DeepMindplaceholder alt text
By Beatrice NolanAugust 10, 2026
Economy
U.S. Treasury is paying $3 billion a day in interest on national debt, says the CBO—having spent $10 billion to prop up the currency of its top lenderplaceholder alt text
By Eleanor PringleAugust 11, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.